Overview
ZBH market data
Price History
ZBH price chart
Valuation & Profitability
- P/E (TTM)
- 24.52 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $3.55 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.47 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 103.6% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $79.12 – $108.29 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $18.7K · P/B 1.40 · P/S 2.22.
Company News
Shares of medical device-related companies are trading higher following comments from HCA Healthcare on a conference call that business declines from uninsured patients didn't occur as expected in Q2, which is bullish for the medical device and equipment outlook following the end of ACA subsidies.Benzinga · Jul 24, 2026, 5:51 PM
Shares of medical device-related companies are trading lower after HCA Healthcare noted a Q2 increase in uninsured patient volumes and a decline in surgical volume, which may dim the outlook for device pricing power and margins.Benzinga · Jul 14, 2026, 5:07 PM
Live On CNBC, Sarat Sethi Announces Sold Zimmer BiometBenzinga · Jul 13, 2026, 5:02 PM
Explosive Growth in AI for Orthopedic Surgery Market: $0.87 Billion by 2030 at 27.2% CAGRGlobenewswire Inc · Jul 10, 2026, 3:15 PM
BMO Capital Initiates Coverage On Zimmer Biomet Holdings with Market Perform Rating, Announces Price Target of $95Benzinga · Jul 9, 2026, 3:10 PM
Surgical Navigation System Report; Patent Leadership Led by the United States with 1,204 Patents In 230-Page Patent Landscape Covering Neurosurgery, Spinal, Orthopaedic, ENT, and Dental Navigation ApplicationsGlobenewswire Inc · Jul 9, 2026, 11:15 AM
Evercore ISI Group Maintains Outperform on Zimmer Biomet Holdings, Lowers Price Target to $110Benzinga · Jul 6, 2026, 5:10 PM
Reported Earlier: 'Medical device maker Zimmer Biomet to hire 500 in 3 years for tech centre in India' - ReutersBenzinga · Jul 2, 2026, 11:50 AM
AI Chips Power Wall Street Higher, Dow Eyes Records: Stock Market TodayBenzinga · Jun 30, 2026, 5:30 PM
Pacira BioSciences Divests Iovera To Zimmer Biomet For Up To $140MBenzinga · Jun 30, 2026, 11:40 AM